Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

Clinical trials should be considered at any point in a patient's journey with HER2-positive metastatic breast cancer, not just when standard options are exhausted, as they provide early access to promising therapies, novel combinations, and cutting-edge care.

Related Content:

Navigating HER2+ Metastatic Breast Cancer TreatmentBreast Cancer

Breast Cancer Survivor Advocates for Access to Scalp Cooling

Scalp Cooling Can Prevent Hair Loss During Chemo for Breast Cancer

Dealing With Peripheral Neuropathy After Breast Cancer Treatment